Business Novavax stock drops even after Japan approves its COVID vaccine Published 3 years ago on 19 April 2022 By Terry Power Novavax stock drops even after Japan approves its non-mRNA COVID vaccine | Fortune You need to enable JavaScript to view this site. Related Topics:ApprovesCOVIDDropsJapanjapan adds novavaxjapan approves novavaxNovavaxnovavax approval japannovavax canadanovavax covid vaccinenovavax fdanovavax japannovavax stocknovavax stock pricenovavax vaccinestockvaccine